|This product is only available for shipping to the following countries - Andorra, Austria, Belarus, Belgium, Bulgaria, China , Croatia (formerly part of YUG 891), Cyprus, Czech Republic, Denmark, Finland, France, Georgia, Gibraltar, Greece, Greenland, Hong Kong, Hungary, Iceland, India, Ireland, Israel, Italy, Japan, Lebanon, Liechtenstein, Lithuania, Luxembourg, Macau, Monaco, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United Kingdom, United States, United States Minor Outlying Islands, Uzbekistan, Virgin Islands (British), Virgin Islands (US).|
|Manufacturer:||ASTRA ZENECA manufactures Accolate.|
|Uses:||The uses of Accolate include:|
Product Origin: EU (Turkey)
This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.
Accolate helps prevent asthma attacks. It is prescribed for long-term treatment.
Accolate (zafirlukast) is an oral leukotriene receptor antagonist (LTRA) for the maintenance treatment of asthma. Available as a tablet, it blocks the effects of substances which cause constriction of the airways, build-up of mucus in the lungs and inflammation of the breathing passages.
Accolate was the first LTRA to be marketed in the USA and is now approved in over 60 countries, including the UK, Japan, Italy, Spain, Canada, Brazil and China.
Accolate is approved in the USA for adults and children aged 5 years and above.
Accolate will not stop an asthma attack once it starts. You will still need to use an airway-opening medication when an attack occurs.
ADULTS The usual dose for adults and children 12 years of age and over is 20 milligrams twice a day.
The usual dose for children 7 to 11 years of age is 10 milligrams twice a day. Safety and effectiveness in children under 7 years of age have not been established.